title: NMDA receptor-dependent high-frequency network oscillations (100-300 Hz) in rat hippocampal slices.
abstract: High-frequency oscillations (HFOs or ripples, >or=100 Hz) appear to be important expressions of cortical circuits, characterizing physiological and pathological functional states. Synaptic and non-synaptic mechanisms are involved in their generation. This study shows that spontaneous N-methyl-D-aspartate receptor (NMDAR) mediated potentials, recorded in dorsal and ventral hippocampal slices perfused with magnesium-free medium and antagonists of non-NMDARs and GABA receptors were associated with high-frequency oscillations (100-300 Hz), recorded in all hippocampal subregions. Both CA3 and CA1 regions displayed HFOs at the range of 180-300 Hz with oscillations in CA3 being significantly faster than in CA1 (232+/-22 Hz, n=64 slices versus 206+/-18 Hz, n=24, P<0.001). Moreover, in most of the slices (39/63) the CA1 network oscillated also at a lower frequency (121.8+/-2.45 Hz). Simultaneous recordings showed that activity was most often initiated in CA3 region; however, dentate gyrus and CA1 were potential sites of generation as well. The incidence of spontaneous events was significantly higher in ventral than in dorsal slices (20+/-1.6/min versus 5.4+/-0.3/min, P<0.001). The competitive and non-competitive NMDAR antagonists, d-AP5 (50 microM) and MK 801 (50 microM), respectively abolished spontaneous activity. The gap-junction blocker carbenoxolone significantly suppressed spontaneous activity in a concentration-dependent manner. These data indicate that synaptic transmission provided by solely NMDARs can sustain the generation of high-frequency network oscillations, which display distinct characteristics in CA3 and CA1 subregions.
authors.affiliation: University of Patras, Department of Physiology, Medical School, 26504 Rio, Patras, Greece. cepapath@med.upatras.gr
authors.forename: Costas
authors.initials: C
authors.lastname: Papatheodoropoulos
mesh_terms: D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology; D001683:Biological Clocks / Q000187:drug effects / Q000502:physiology*; D002229:Carbenoxolone / Q000494:pharmacology; D003344:Cortical Synchronization / Q000187:drug effects; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D018756:GABA Antagonists / Q000494:pharmacology; D017629:Gap Junctions / Q000187:drug effects / Q000378:metabolism; D018698:Glutamic Acid / Q000378:metabolism; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009415:Nerve Net / Q000187:drug effects / Q000378:metabolism*; D009434:Neural Pathways / Q000187:drug effects / Q000378:metabolism*; D009924:Organ Culture Techniques; D051381:Rats; D017208:Rats, Wistar; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology*
chemical_list: D000897:Anti-Ulcer Agents; D018691:Excitatory Amino Acid Antagonists; D018756:GABA Antagonists; D016194:Receptors, N-Methyl-D-Aspartate; D018698:Glutamic Acid; D002229:Carbenoxolone